The symptoms experienced by those who suffer from chronic fatigue may be related to acute inflammation in the brain, according to a PET study published March 24 in the Journal of Nuclear Medicine.

The worldwide market for radiopharmaceuticals is expected to round out at a compound annual growth rate of 18.39 percent every year from 2012 through 2016, according to a report announced March 26 by research firm TechNavio.

Quantitative susceptibility mapping (QSM) can quantify the magnetic susceptibility of multiple sclerosis (MS) lesions in vivo, according to a study published in the April issue of Radiology. 

Full-spectrum endoscopy offers a technological advancement for colonoscopy as it could improve the efficacy of colorectal cancer screening and surveillance, according to a study published in the March issue of the Lancet Oncology. 

Women with breast cancer and a history of mantle radiation therapy for Hodgkin disease predominantly exhibit cancer occurrence within the upper outer quadrant of the breast, according to a study published in the April issue of Radiology. 

Pharmaceutical company NeuroPhage has nailed $15 million in financing for therapeutic drugs for neurodegenerative disorders including Alzheimer’s disease and Parkinson's, the company announced March 25.

Type two diabetes definitively leads to neuronal injury, but the jury is still out whether it contributes to the buildup of beta-amyloid in the brain associated with Alzheimer’s disease, according to a study published March 20 by the Journal of Nuclear Medicine.

A community-wide evaluation of myocardial perfusion imaging (MPI) use throughout the Kaiser Permanente Northern California health system revealed an unexplainable 51 percent dip in MPI from 2006-2011, according to research published today in the Journal of the American Medical Association.